Clinical effects of cognitive behavioral therapy in heart failure patients: a meta-analysis of randomized controlled trials.
And Meta-analysis
Anxiety
Cognitive behavioral therapy
Depression
Heart failure care
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
07 Aug 2023
07 Aug 2023
Historique:
received:
18
02
2023
accepted:
03
08
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
About 20-40% of people with Heart failure (HF) suffer from some depression, which is 4-5% greater than the overall population. This depression can lead to undesirable outcomes, including elevated mortality rate and frequent hospitalization. The current study aims to evaluate the impact of cognitive behavioural therapy (CBT) on self-care and the symptoms of depression and anxiety in HF patients. We searched PubMed, Web of Science (WOS), Scopus, and Cochrane Library till 15 October 2022. All relevant randomized controlled trials (RCTs) were included. The data were extracted and pooled using Review Manager software (RevMan 5.4). Continuous data were pooled as mean difference and 95% confidence interval (CI). Our search retrieved 1146 records, and 7 studies (611 patients) were finally included. We assessed the Beck Depression Inventory-II (BDI-II) as the primary outcome of the study. Hamilton Rating Scale for Depression (HRSD-17), Change in Beck Anxiety Inventory, Kansas City Cardiomyopathy Questionnaire (KCCQ), and Self-Care of Heart Failure Index (SCHFI) were also assessed as secondary outcomes. With CBT, BDI-II showed a significant reduction after 4 to 6 months follow-up (MD = -4.87, 95% CI: [-8.06; -1.69], P = 0.003) as well as 8 to 9 months follow-up (MD = -5.71, 95% CI: [-8.95; -2.46], P = 0.0006). But no significant difference was shown with 3 months follow-up (M.D=-4.34; 95%CI: [-10.70; 2.03], P = 0.18). CBT has long-term (4-9 months) significant favorable outcomes decreasing anxiety and depression compared to non-CBT groups. No significant short-term (less than 3 months) impact on HF patients' self-care, depression, or anxiety were shown.
Sections du résumé
BACKGROUND
BACKGROUND
About 20-40% of people with Heart failure (HF) suffer from some depression, which is 4-5% greater than the overall population. This depression can lead to undesirable outcomes, including elevated mortality rate and frequent hospitalization.
PURPOSE
OBJECTIVE
The current study aims to evaluate the impact of cognitive behavioural therapy (CBT) on self-care and the symptoms of depression and anxiety in HF patients.
METHODS
METHODS
We searched PubMed, Web of Science (WOS), Scopus, and Cochrane Library till 15 October 2022. All relevant randomized controlled trials (RCTs) were included. The data were extracted and pooled using Review Manager software (RevMan 5.4). Continuous data were pooled as mean difference and 95% confidence interval (CI).
RESULTS
RESULTS
Our search retrieved 1146 records, and 7 studies (611 patients) were finally included. We assessed the Beck Depression Inventory-II (BDI-II) as the primary outcome of the study. Hamilton Rating Scale for Depression (HRSD-17), Change in Beck Anxiety Inventory, Kansas City Cardiomyopathy Questionnaire (KCCQ), and Self-Care of Heart Failure Index (SCHFI) were also assessed as secondary outcomes. With CBT, BDI-II showed a significant reduction after 4 to 6 months follow-up (MD = -4.87, 95% CI: [-8.06; -1.69], P = 0.003) as well as 8 to 9 months follow-up (MD = -5.71, 95% CI: [-8.95; -2.46], P = 0.0006). But no significant difference was shown with 3 months follow-up (M.D=-4.34; 95%CI: [-10.70; 2.03], P = 0.18).
CONCLUSIONS
CONCLUSIONS
CBT has long-term (4-9 months) significant favorable outcomes decreasing anxiety and depression compared to non-CBT groups. No significant short-term (less than 3 months) impact on HF patients' self-care, depression, or anxiety were shown.
Identifiants
pubmed: 37550665
doi: 10.1186/s12906-023-04117-2
pii: 10.1186/s12906-023-04117-2
pmc: PMC10405476
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
280Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Contemp Nurse. 2007 May-Jun;25(1-2):50-61
pubmed: 17622989
Harv Rev Psychiatry. 2014 Sep-Oct;22(5):295-305
pubmed: 25126762
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Patient Educ Couns. 2016 Apr;99(4):512-521
pubmed: 27045976
Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):351-9
pubmed: 23763532
Heart Fail Rev. 2017 Nov;22(6):731-741
pubmed: 28733911
J Am Coll Cardiol. 2001 Jul;38(1):199-205
pubmed: 11451275
Gen Hosp Psychiatry. 2007 Sep-Oct;29(5):379-87
pubmed: 17888803
BMC Geriatr. 2022 Apr 5;22(1):281
pubmed: 35382758
Heart Lung. 2012 Sep-Oct;41(5):469-83
pubmed: 22938627
Br J Health Psychol. 2002 Feb;7(Pt 1):11-21
pubmed: 14596714
Int J Nurs Stud. 2016 Sep;61:219-29
pubmed: 27400028
J Educ Health Promot. 2014 Jun 23;3:70
pubmed: 25077163
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Am Coll Cardiol. 2004 May 5;43(9):1550-2
pubmed: 15120810
J Psychosom Res. 2010 Aug;69(2):119-31
pubmed: 20624510
Medicine (Baltimore). 2016 Dec;95(52):e5353
pubmed: 28033244
J Med Internet Res. 2016 Aug 03;18(8):e194
pubmed: 27489077
J Psychosom Res. 2007 Apr;62(4):427-37
pubmed: 17383494
Curr Biol. 2017 Jul 24;27(14):R713-R715
pubmed: 28743020
Appl Nurs Res. 2016 Aug;31:86-93
pubmed: 27397824
Am Heart J. 2005 Oct;150(4):707-15
pubmed: 16209970
JAMA Intern Med. 2015 Nov;175(11):1773-82
pubmed: 26414759
J Card Fail. 2012 Jan;18(1):10-20
pubmed: 22196836
J Cardiovasc Thorac Res. 2015;7(3):113-7
pubmed: 26430499
Eur J Heart Fail. 2022 Jan;24(1):4-131
pubmed: 35083827
Circ Heart Fail. 2022 Aug;15(8):e009422
pubmed: 35973032
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Perspect Psychiatr Care. 2022 Oct;58(4):2791-2799
pubmed: 35616368